Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma
Asthma, a family of airway disorders characterized by airway inflammation, has an increasing incidence worldwide. Platelet-activating factor (PAF) may play a role in the pathophysiology of asthma. Its proinflammatory actions are antagonized by PAF acetylhydrolase. A missense mutation (V279F) in the...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
1999
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC408260/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10194471/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI5574 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
